Table 4.
Indication | Lithium | Carbamazepine oxcarbazepine | Valproate | Lamotrigine | Risperidone | Olanzapine | Quetiapine | Ziprasidone | Aripiprazole |
---|---|---|---|---|---|---|---|---|---|
Mania
|
|
|
|
|
|
|
|
|
|
Rapid cycling | ± | +? | + | + | ? | + | ? | ? | ? |
Use in hepatic disease | + | ± | ? | + | + | +(1) | + | + | + |
Use in renal disease | - | + | + | + | - | + | + | + | + |
Use in rash patients | + | ± | + | ? | + | + | + | + | + |
Medical-induced mania | - | + | + | ? | +? | + | ? | + | + |
Violence/rapid stabilization | ?+ | ?+ | + | - | +? | + | ? | + | ? |
Substance comorbidity | - | + | + | ? | ? | + | ? | ? | ? |
Long-term depression | + | ? | ? | + | ? | +(2) | ? | ? | ? |
FDA Class | D | D/C | D | C | C | C | C | C | C |
Breastfeeding | - | + | + | - | - | - | - | - | - |
Hormone effects | - | Ind. OC(3) | ? | - | Prolactin | - | - | - | - |
Short-term side effects | Cognition Polydip. Tremor | Sedation Anemia LFT elev. | Sedation Weight gain LFT elev. | Rash Headache | Wt. gain EPS(4) Gluc. elev.(5) | Weight gain Sedation Gluc. elev | Gluc. elev | Agitation Sedation | Agitation |
Long-term side effects | Thyroid Renal | Anemia | Pan's? PCO | - | T.D.? Chol. elev. | T.D.? Chol. elev. | T.D.? Chol. elev. | T.D.? | T.D.? |
Dosing | 600-2400 (0.6–1.2) QD or BID | 400–1200/ 600–1800 BID | 750–2500(6) (50–125) BID | 100mg BID | 2–6mg BID | 5–20mg HS | 300–600mg BID | 40–80mg BID | 10–30mg AM |
Notes: Evidence base—haloperidol and thioridizine also FDA-approved for mania, but not commonly used.
- (1)
Olanzapine—Rare reports of LFT elevation
- (2)
Option to use combined form (olanzapine/fluoxetine = Symbyax).
- (3)
Induction of oral contraceptives—carbamazepine oxcarbazepine and topiramate.
- (4)
Risperdone—EPS = extrapyramidal side effects and TD = tardive dyskinesia.
- (5)
Glucose and cholesterol elevation—may be more for olanzapine, risperidone, and quetiapine than for ziprasidone and aripiprazole.
- (6)
Valproate ER dosed 500–3000mg HS.